These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2994402)

  • 1. Seroepidemiological studies on nasopharyngeal carcinoma in China.
    Zeng Y
    Adv Cancer Res; 1985; 44():121-38. PubMed ID: 2994402
    [No Abstract]   [Full Text] [Related]  

  • 2. [A study of the practical value of the immunoenzyme method in seroepidemiological field surveys].
    Wu JM
    Zhonghua Liu Xing Bing Xue Za Zhi; 1988 Apr; 9(2):107-10. PubMed ID: 2842055
    [No Abstract]   [Full Text] [Related]  

  • 3. Differences in EBV antibody titres of patients with nasopharyngeal carcinoma originating from high, intermediate and low incidence areas.
    de-The G; Lavoue MF; Muenz L
    IARC Sci Publ (1971); 1978; (20):471-81. PubMed ID: 215529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA and nasopharyngeal carcinoma.
    Desgranges C; De-The G
    IARC Sci Publ (1971); 1978; (24 Pt 2):883-91. PubMed ID: 221410
    [No Abstract]   [Full Text] [Related]  

  • 5. Epstein-Barr-specific IgA in nasopharyngeal cancer.
    Lancet; 1978 Jun; 1(8078):1345-6. PubMed ID: 78104
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-EBV antibody titers in Italian patients with nasopharyngeal carcinoma.
    Pirodda E; Caliceti U; Testoni S
    J Exp Pathol; 1987; 3(4):479-83. PubMed ID: 2842481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.
    Henle W; Henle G; Ho JH
    IARC Sci Publ (1971); 1978; (20):427-37. PubMed ID: 215525
    [No Abstract]   [Full Text] [Related]  

  • 8. Nasopharyngeal carcinoma due to Epstein-Barr virus: serologic tests.
    Smith TF
    Mayo Clin Proc; 1985 Mar; 60(3):205-6. PubMed ID: 2983152
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of the Epstein-Barr herpesvirus relationship with Hodgkin's disease and the use of virus immunological markers in differential diagnostics of nasopharyngeal carcinoma.
    Mazurenko NP; Gurtsevich VE; Stepina VN; Plakhov IV
    Arch Geschwulstforsch; 1983; 53(3):253-9. PubMed ID: 6311138
    [No Abstract]   [Full Text] [Related]  

  • 10. The Chinese epidemiological approach of nasopharyngeal carcinoma research and control.
    De-Thé G
    Yale J Biol Med; 1981; 54(1):33-9. PubMed ID: 6264696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Humoral response to Epstein-Barr virus of patients with nasopharyngeal cancer and its use in the differential diagnosis of the disease].
    Gurtsevich VE; Plakhov IV; Chuĭkina NA; Abdulin NA
    Vestn Akad Med Nauk SSSR; 1984; (5):29-34. PubMed ID: 6331022
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rhinopharyngeal carcinoma and Epstein-Barr virus: study of a sample of Italian patients].
    Caliceti U; Cevenini R; Donati M
    Acta Otorhinolaryngol Ital; 1985; 5(1):83-90. PubMed ID: 2994355
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of subclinical nasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy.
    Sham JS; Wei WI; Zong YS; Choy D; Guo YQ; Luo Y; Lin ZX; Ng MH
    Lancet; 1990 Feb; 335(8686):371-4. PubMed ID: 1968116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of serologic test for EB-virus antibody in occult type nasopharyngeal carcinoma.
    Furukawa M; Takimoto T; Morishita K; Komori T; Ishiguro H; Umeda R
    Auris Nasus Larynx; 1983; 10(1):43-8. PubMed ID: 6311149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasopharyngeal carcinoma. Brief review.
    Fedder M; Gonzalez MF
    Am J Med; 1985 Sep; 79(3):365-9. PubMed ID: 2994473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of EB virus-specific IgA antibody from patients with nasopharyngeal carcinoma by immunoenzymic method (author's transl)].
    Liu YX; Zeng Y; Dong WP; Cao GR
    Zhonghua Zhong Liu Za Zhi; 1979; 1(1):8-12. PubMed ID: 233233
    [No Abstract]   [Full Text] [Related]  

  • 17. [A modified 131 I immuno-autoradiographic method for detection of serum EB virus VCA-IgA antibody in nasopharyngeal carcinoma].
    Shang M
    Zhonghua Zhong Liu Za Zhi; 1982 Nov; 4(4):262-4. PubMed ID: 6299669
    [No Abstract]   [Full Text] [Related]  

  • 18. Seroepidemiological studies on carcinoma of the nasopharynx.
    Lin TM; Yang CS; Chiou JF; Tu SM; Lin CC; Liu CH; Chen KP; Ito Y; Kawamura A; Hirayama T
    Cancer Res; 1973 Nov; 33(11):2603-8. PubMed ID: 4355974
    [No Abstract]   [Full Text] [Related]  

  • 19. Application of an immunoenzymatic method and an immunoautoradiographic method for a mass survey of nasopharyngeal carcinoma.
    Yi Z; Yuxi L; Chunren L; Sanwen C; Jihneng W; Jisong Z; Huijong Z
    Intervirology; 1980; 13(3):162-8. PubMed ID: 6246033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of 2 families with clustering of nasopharyngeal carcinoma and detection of serum VCA-IgA antibody among their members].
    Tang ZH
    Zhonghua Yi Xue Za Zhi; 1983 Sep; 63(9):553-5. PubMed ID: 6317146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.